Skip to content

ICU Medical CH3955Recalls & reported problems

Icu Medical, Inc. · ChemoClave™ Bag Spike with Additive Port, ChemoClave™ · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
8
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00887709098305), received between Jun 12, 2025 and Aug 27, 2026 — classified as 8 malfunctions.

The most frequently reported specific device problem is “Fluid/Blood Leak” (5 reports).

9 other recalls cover devices cleared under the same FDA submission (K173477); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 4 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 3 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520264
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fluid/Blood Leak5
  • No Flow2
  • Obstruction of Flow1

Patient problems

  • No Clinical Signs, Symptoms or Conditions6
  • Chemical Exposure2

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 27, 2026No Flow

    The event involved a ChemoClave Bag Spike with Additive Port, ChemoClave reported that when spiking the ifosfamide bag to Circle Prime, the clave depressed and malfunctioned, and no fluid was able to leave the IV bag into the tubing. Pharmacy re-made the dose due to the spike malfunction, and the same thing happened a second time. The bag spike depressed too far, and no fluid was able to flow from the bag. The event occurred during patient use. There was a delay in therapy. There was patient involvement and no harm.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50475541 ↗
  • MalfunctionAug 24, 2026Fluid/Blood Leak

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50417283 ↗
  • MalfunctionAug 7, 2026Obstruction of Flow

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50177727 ↗
  • MalfunctionAug 22, 2025No Flow; No Flow

    THE EVENT OCCURRED ON AN UNSPECIFIED DATE AND INVOLVED A CHEMOCLAVE¿ BAG SPIKE WITH ADDITIVE PORT, CHEMOCLAVE¿. IT WAS REPORTED THAT CHEMOTHERAPY WOULD NOT FLOW AFTER IT HAS BEEN SPIKED BY PHARMACY, SEEMING LIKE THE VERTICAL CLAVE WAS COMPRESSED. MULTIPLE EVENTS OCCURRED THROUGHOUT JULY AND THIS WEEK. THE CHEMO DID COME INTO CONTACT WITH THE PATIENT OR HEALTHCARE PROVIDER. THERE WAS AN UNSPECIFIED DELAY IN PATIENT CARE; INCREASED TIME/SCRAMBLING WITH NURSING AND PHARMACY TO RE-SPIKE THE BAG. THE STAFF REPORTED A SAFETY CONCERN WITH MORE MANIPULATION TRYING TO GET IT TO WORK. INCREASE IN CENTRAL LINE ACCESS. THERE WAS NO SPILL. THE ISSUE OCCURRED DURING USE ON PATIENTS. THERE WAS NO ADVERSE EVENT OR HUMAN HARM.

    Patient problems: Chemical Exposure

    MAUDE report 22877241 ↗
  • MalfunctionJun 24, 2025Fluid/Blood Leak; Fluid/Blood Leak

    THE REPORTED COMPLAINT INVOLVED A CHEMOCLAVE¿ BAG SPIKE WITH ADDITIVE PORT, CHEMOCLAVE¿. THE REPORTER ORIGINALLY STATED THAT A SPIROS BROKE WHILE A NURSE WAS HANDLING ICU MEDICAL PRODUCT PRIOR TO GIVING AN UNSPECIFIED CHEMOTHERAPY DRUG TO THE PATIENT AND THE CHEMO SPILLED ALL OVER THE NURSE. ADDITIONAL INFORMATION WAS SUBSEQUENTLY PROVIDED BY THE CUSTOMER REFERRING TO THE POSSIBLE LIST NUMBER OF CH3955. THERE WAS NO OTHER CLINICAL CONSEQUENCE TO THE NURSE OR THE PATIENT REPORTED.

    Patient problems: Chemical Exposure

    MAUDE report 22323139 ↗
  • MalfunctionJun 19, 2025Fluid/Blood Leak; Fluid/Blood Leak

    THE EVENT OCCURRED ON AN UNSPECIFIED DATE(S) BETWEEN LATE APRIL THROUGH MAY AND INVOLVED A CHEMOCLAVE¿ BAG SPIKE WITH ADDITIVE PORT, CHEMOCLAVE¿ WHERE THE CUSTOMER REPORTED THAT THERE HAVE BEEN EVENTS OF LEAKING. THE CUSTOMER STATED THAT THE LEAKAGE WAS NOTED AT CONNECTION POINT OF BLUE PORT AND WHITE BODY OF CHEMOCLAVE AND THAT THE UNSPECIFIED CHEMOTHERAPY ADMINISTRATION WAS DELAYED. ALTHOUGH THERE WAS PATIENT INVOLVEMENT, HARM WAS NOT REPORTED AS A CONSEQUENCE OR THE EVENT(S).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22294512 ↗
  • MalfunctionJun 12, 2025Fluid/Blood Leak; Fluid/Blood Leak

    IT WAS REPORTED THAT, ON AN UNSPECIFIED DATE IN LATE APRIL, A CHEMOCLAVE¿ BAG SPIKE WITH ADDITIVE PORT, CHEMOCLAVE¿ GENERATED A LEAK DURING PATIENT USE. THE REPORTER STATED THAT THERE HAVE BEEN EVENTS OF STICK DOWN AND LEAKS. THERE WAS NO PATIENT HARM REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22196010 ↗
  • MalfunctionJun 12, 2025Fluid/Blood Leak; Fluid/Blood Leak

    IT WAS REPORTED THAT, ON AN UNSPECIFIED DATE IN MAY, A CHEMOCLAVE¿ BAG SPIKE WITH ADDITIVE PORT, CHEMOCLAVE¿ GENERATED A LEAK DURING PATIENT USE. THE REPORTER STATED THAT THERE HAVE BEEN EVENTS OF STICK DOWN AND LEAKS. THERE WAS NO PATIENT HARM REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22196003 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K173477. One submission often covers many models, so check the product and lot details in each record.

  • Z-3159-2026 · May 12, 2026 · Open, Classified
    Oncology sets with drip chambers
  • Z-3161-2026 · May 12, 2026 · Open, Classified
    IV Sets with drip chambers
  • Z-1577-2021 · Mar 16, 2021 · Open, Classified
    REF CH2060 60mL Syringe w/Spinning Spiros, Red Cap - Product Usage: provides access for the administration of fluids from a container to a patient s vascular system through the adm
  • Z-1579-2021 · Mar 16, 2021 · Open, Classified
    REF CH3020 40" (102 cm) Appx. 4.8 ml, 20 Drop Admin Set w/In-Line Chamber, 2 Spiros", Hanger - Product Usage: provides access for the administration of fluids from a container to a
  • Z-1578-2021 · Mar 16, 2021 · Open, Classified
    REF CH3011 30" (76 cm) Appx 3.3 mL, 20 Drop Admin Set w/Integrated ChemoClave Drip Chamber, Spiros w/Red Cap, Bag Hanger - Product Usage: provides access for the administration o
  • Z-1576-2021 · Mar 16, 2021 · Open, Classified
    REF CH2020 20mL Syringe w/Spinning Spiros, Red Cap - Product Usage: provides access for the administration of fluids from a container to a patient s vascular system through the adm
  • Z-1580-2021 · Mar 16, 2021 · Open, Classified
    REF CH3625 5" (13 cm) Appx 0.50 ml, Smallbore Trifuse Ext Set w/3 ChemoClave (Purple, Green Rings), Spiros w/Red Cap, 3 Clamps - Product Usage: provides access for the administrat
  • Z-0704-2021 · Aug 31, 2020 · Open, Classified
    3mL Syringe w/Spinning Spiros, Red Cap, REF: CH2003; 5mL Syringe w/Spinning Spiros, Red Cap, REF: CH2005; 10mL Syringe w/Spinning Spiros, Red Cap, REF: CH2010; 20mL Syringe w/Spinn
  • Z-0248-2021 · Jul 6, 2020 · Terminated
    6.5 IN (17 cm) APPX 0.78 ml, Ext Set w/Clave Clear, Clave 4-Way Stopcock, Spiros Red Cap;1 unit per pouch, 50 pouches per case. UDI:(01)10887709098878(17)241201(30)50(10)4493149.

Other Closed antineoplastic and hazardous drug reconstitution and transfer system devices

All Closed antineoplastic and hazardous drug reconstitution and transfer system devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page